Skip to content

Exploratory Clinical Trial Evaluating the Efficacy and Safety of HAL Treatment in Children With Spinal Cord Disorders and Gait Impairment

Exploratory Clinical Trial Evaluating the Efficacy and Safety of HAL Treatment in Children With Spinal Cord Disorders and Gait Impairment

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032250684
Enrollment
10
Registered
2026-01-27
Start date
2026-02-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children With Spinal Cord Disorders and Gait Impairment

Interventions

The HAL lower-limb intervention will be conducted once per day for 30 minutes, 1 to 4 times per week (for a total of 12 sessions). A session will be considered valid if at least 15 minutes are complet
sessions lasting less than 15 minutes will not be counted. The intervention program aims to improve walking ability and consists of sit-to-stand training, standing training, and gait training using HA

Sponsors

Marushima Aiki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients whose legal representative can provide written informed consent. 2) Patients aged 5 to 15 years. 3) Patients who are at least 12 months post-onset. 4) Patients classified as Frankel grade C or D, or Sharrard grade 1 - 4. 5) Patients who are able to walk a distance of 10 meters (with walking aids permitted). 6) Patients who can be fitted with HAL size S or 2S. 7) Patients who can remain hospitalized or attend outpatient visits according to the study schedule during the research period.

Exclusion criteria

Exclusion criteria: 1) Patients who have impaired consciousness or severe intellectual disability that makes it difficult to perform voluntary limb movements in response to instructions. 2) Patients with severe skeletal deformities - such as osteoarthritis, spondylosis deformans, or scoliosis - that make joint-movement training or HAL fitting difficult. 3) Patients with comorbidities that may interfere with training, such as bleeding tendencies or osteoporosis. 4) Patients who cannot have HAL bioelectrodes applied due to skin diseases or related conditions. 5) Patients who have participated in another study within 12 weeks prior to the start of this clinical research. 6) Patients judged as unsuitable for participation in this study by the principal investigator or sub-investigators.

Design outcomes

Primary

MeasureTime frame
2-minute walk test

Secondary

MeasureTime frame
10-Meter Walk Test (self-selected walking speed) Walking Index for Spinal Cord Injury II (WISCI-II) Lower Extremity Motor Score (LEMS) Modified Ashworth Scale (MAS) Trunk Activity Scale for Spinal Cord Injury (TASS) Canadian Occupational Performance Measure (COPM) Japanese Version of the Decision Regret Scale (Japanese DRS) Changes in lower-limb joint angles during gait Changes in lower-limb muscle activity during gait

Contacts

Public ContactKazushi Takahashi

University of Tsukuba

takahashi.kazushi.fn@u.tsukuba.ac.jp+81-29-853-3674

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026